ABOUT US PIPELINE INVESTORS CAREERS CORPORATE SOCIAL RESPONSIBILITY In Bavarian Nordic, we contribute to the society by developing and manufacturing vaccines that provide protection against deadly diseases and new therapies holding the potential to improve the future treatment of cancer patients. While seeking to create a growing, sustainable business, we are committed to being socially and environmentally responsible and to comply with all relevant laws, standards and guidelines. We maintain a strong corporate governance structure and communicate openly and transparently about our CSR efforts, which are primarily concentrated on five focus areas: our products, our environment, our employees, our suppliers and business ethics. We account annually for the development in these areas in our Corporate Social Responsibility (CSR) report which constitutes an independent part of the annual report. Download our CSR reports FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

ABOUT US PIPELINE INVESTORS CAREERS MANUFACTURING Bavarian Nordic operates its own commercial-scale manufacturing facility in Kvistgaard, Denmark allowing Bavarian Nordic to manufacture, analyze and release sterile vaccines for use in humans in accordance with full EU cGMP requirements. The multi-purpose facility is manufacturing IMVANEX® smallpox vaccine and MVA-BN® Filo (Ebola vaccine) as well as other MVA-BN based vaccines and other poxvirus based products for clinical purposes. COMPANY OVERVIEW Cancer Immunotherapy Infectious Diseases Manufacturing FACTS EU cGMP compliant facility Inspected by the FDA Has manufactured 28 million doses of IMVAMUNE® smallpox vaccine to the U.S. Strategic National Stockpile Has also manufactured 2 million doses of MVA-BN Filo for Janssen as part of their Ebola vaccine regimen FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.

ABOUT US PIPELINE INVESTORS CAREERS BOARD COMMITTEE CHARTERS Finance, Risk and Audit Committee Terms of Reference Download PDF Nomination and Compensation Committee Terms of Reference Download PDF CORPORATE GOVERNANCE Board Composition and Work Board Committees Board Committee Charters Diversity in the Board Remuneration Policy Articles of Association FOLLOW US QUICK LINKS Contact Us Media Careers Partnering OUR LOCATIONS © 2017 Bavarian Nordic | Disclaimer/Privacy | Cookies | Sitemap This website uses cookies to collect statistical information on the use of our website with the goal of improving user experience. To find out more about cookies on this website, see our cookie policy.